Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Chinese Patent Office

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,707,975

« Back to Dashboard

Summary for Patent: 5,707,975

Title: Oral formulations on an antifungal
Abstract:The present invention concerns a formulation for oral administration comprising an antifungal, a sufficient amount of a cyclodextrin or a derivative thereof, an aqueous acidic medium as bulk liquid carrier and an alcoholic co-solvent Addition of one or more pharmaceutically acceptable sweeteners and one or more pharmaceutically acceptable flavors thereto yields palatable oral formulations. A process of preparing such formulations and pharmaceutical dosage forms comprising said formulations.
Inventor(s): Fran.cedilla.ois; Marc Karel Jozef (Kalmthout, BE), Dries; Willy Maria Albert Carlo (Merksplas, BE)
Assignee: Janssen Pharmaceutica, N.V. (Beerse, BE)
Application Number:08/604,950
Patent Claim Types:
see list of patent claims
Formulation; Dosage form; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,707,975

PCT Information
PCT FiledSeptember 22, 1994PCT Application Number:PCT/EP94/03169
PCT Publication Date:April 06, 1995PCT Publication Number: WO95/08993

International Patent Family for Patent: 5,707,975

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
HungaryT74378► Subscribe
China1086579► Subscribe
Cyprus2272► Subscribe
Czech Republic9600823► Subscribe
Czech Republic288026► Subscribe
Germany69429359► Subscribe
Denmark0721337► Subscribe
European Patent Office0721337► Subscribe
Spain2169087► Subscribe
Finland961436► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus